Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Combinatorial Selection and Binding of Phosphorothioate Aptamers Targeting Human NF-κB RelA(p65) and p50†

Identifieur interne : 003365 ( Main/Exploration ); précédent : 003364; suivant : 003366

Combinatorial Selection and Binding of Phosphorothioate Aptamers Targeting Human NF-κB RelA(p65) and p50†

Auteurs : David J. King [États-Unis] ; Suzanne E. Bassett [États-Unis] ; Xin Li [États-Unis] ; Susan A. Fennewald [États-Unis] ; Norbert K. Herzog [États-Unis] ; Bruce A. Luxon [États-Unis] ; Robert Shope [États-Unis] ; David G. Gorenstein [États-Unis]

Source :

RBID : ISTEX:EAEF7686C6B2B2B87278F7154BB46F5AEB9B5A1C

Abstract

Previously, we reported the in vitro combinatorial selection of phosphorothioate aptamers or “thioaptamers” targeting the transcription factor NF-IL6. Using the same approach and purified recombinant human NF-κB proteins RelA(p65) and p50, duplex thioaptamers have been selected that demonstrate high-affinity, competitive binding with the duplex 22-mer binding site, IgκB. Binding energetics of RelA(p65) and p50 homodimers were studied using a quantitative electrophoretic mobility shift assay or EMSA. As a reference system for competitive aptamer binding, the duplex 22-mer phosphoryl binding site known as Igκ was determined to bind each p65 and p50 homodimer with a 1:1 stoichiometry and with affinities, determined by global analysis, Kd = 4.8 ± 0.2 nM for p65 and Kd = 0.8 ± 0.2 nM for p50. A global analysis tool for competitive NF-κB/Igκ binding was developed and utilized to measure the affinity of thioaptamers selected by both p65 and p50. The competition results indicate that the thioaptamers bind and compete for the same NF-κB site as the known promoter element IgκB (Kd = 78.9 ± 1.9 nM for a p65-selected aptamer and 19.6 ± 1.3 nM for a p50-selected thioaptamer). Qualitative gel shift binding experiments with p50 also demonstrate that the nature of enhanced affinity and specificity can be attributed to the presence of sulfur. Collectively, these results demonstrate the feasibility of the thioaptamer in vitro combinatorial selection technology as a method for producing specific, high-affinity ligands to proteins.

Url:
DOI: 10.1021/bi020220k


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Combinatorial Selection and Binding of Phosphorothioate Aptamers Targeting Human NF-κB RelA(p65) and p50†</title>
<author>
<name sortKey="King, David J" sort="King, David J" uniqKey="King D" first="David J." last="King">David J. King</name>
</author>
<author>
<name sortKey="Bassett, Suzanne E" sort="Bassett, Suzanne E" uniqKey="Bassett S" first="Suzanne E." last="Bassett">Suzanne E. Bassett</name>
</author>
<author>
<name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name>
</author>
<author>
<name sortKey="Fennewald, Susan A" sort="Fennewald, Susan A" uniqKey="Fennewald S" first="Susan A." last="Fennewald">Susan A. Fennewald</name>
</author>
<author>
<name sortKey="Herzog, Norbert K" sort="Herzog, Norbert K" uniqKey="Herzog N" first="Norbert K." last="Herzog">Norbert K. Herzog</name>
</author>
<author>
<name sortKey="Luxon, Bruce A" sort="Luxon, Bruce A" uniqKey="Luxon B" first="Bruce A." last="Luxon">Bruce A. Luxon</name>
</author>
<author>
<name sortKey="Shope, Robert" sort="Shope, Robert" uniqKey="Shope R" first="Robert" last="Shope">Robert Shope</name>
</author>
<author>
<name sortKey="Gorenstein, David G" sort="Gorenstein, David G" uniqKey="Gorenstein D" first="David G." last="Gorenstein">David G. Gorenstein</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:EAEF7686C6B2B2B87278F7154BB46F5AEB9B5A1C</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1021/bi020220k</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-1ZX2CVLS-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002745</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002745</idno>
<idno type="wicri:Area/Istex/Curation">002745</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D24</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D24</idno>
<idno type="wicri:doubleKey">0006-2960:2002:King D:combinatorial:selection:and</idno>
<idno type="wicri:Area/Main/Merge">003401</idno>
<idno type="wicri:Area/Main/Curation">003365</idno>
<idno type="wicri:Area/Main/Exploration">003365</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Combinatorial Selection and Binding of Phosphorothioate Aptamers Targeting Human NF-κB RelA(p65) and p50
<ref type="bib" target="#bi020220kAF2">
<hi rend="superscript"></hi>
</ref>
</title>
<author>
<name sortKey="King, David J" sort="King, David J" uniqKey="King D" first="David J." last="King">David J. King</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology and Department ofPathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Bassett, Suzanne E" sort="Bassett, Suzanne E" uniqKey="Bassett S" first="Suzanne E." last="Bassett">Suzanne E. Bassett</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology and Department ofPathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology and Department ofPathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Fennewald, Susan A" sort="Fennewald, Susan A" uniqKey="Fennewald S" first="Susan A." last="Fennewald">Susan A. Fennewald</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology and Department ofPathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Herzog, Norbert K" sort="Herzog, Norbert K" uniqKey="Herzog N" first="Norbert K." last="Herzog">Norbert K. Herzog</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology and Department ofPathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Luxon, Bruce A" sort="Luxon, Bruce A" uniqKey="Luxon B" first="Bruce A." last="Luxon">Bruce A. Luxon</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology and Department ofPathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Shope, Robert" sort="Shope, Robert" uniqKey="Shope R" first="Robert" last="Shope">Robert Shope</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology and Department ofPathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Gorenstein, David G" sort="Gorenstein, David G" uniqKey="Gorenstein D" first="David G." last="Gorenstein">David G. Gorenstein</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Texas</region>
</placeName>
<wicri:cityArea>Department of Human Biological Chemistry and Genetics and Sealy Center for Structural Biology and Department ofPathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Biochemistry</title>
<title level="j" type="abbrev">Biochemistry</title>
<idno type="ISSN">0006-2960</idno>
<idno type="eISSN">1520-4995</idno>
<imprint>
<publisher>American Chemical Society</publisher>
<date type="e-published">2002</date>
<date type="published">2002</date>
<biblScope unit="vol">41</biblScope>
<biblScope unit="issue">30</biblScope>
<biblScope unit="page" from="9696">9696</biblScope>
<biblScope unit="page" to="9706">9706</biblScope>
</imprint>
<idno type="ISSN">0006-2960</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-2960</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Previously, we reported the in vitro combinatorial selection of phosphorothioate aptamers or “thioaptamers” targeting the transcription factor NF-IL6. Using the same approach and purified recombinant human NF-κB proteins RelA(p65) and p50, duplex thioaptamers have been selected that demonstrate high-affinity, competitive binding with the duplex 22-mer binding site, IgκB. Binding energetics of RelA(p65) and p50 homodimers were studied using a quantitative electrophoretic mobility shift assay or EMSA. As a reference system for competitive aptamer binding, the duplex 22-mer phosphoryl binding site known as Igκ was determined to bind each p65 and p50 homodimer with a 1:1 stoichiometry and with affinities, determined by global analysis, Kd = 4.8 ± 0.2 nM for p65 and Kd = 0.8 ± 0.2 nM for p50. A global analysis tool for competitive NF-κB/Igκ binding was developed and utilized to measure the affinity of thioaptamers selected by both p65 and p50. The competition results indicate that the thioaptamers bind and compete for the same NF-κB site as the known promoter element IgκB (Kd = 78.9 ± 1.9 nM for a p65-selected aptamer and 19.6 ± 1.3 nM for a p50-selected thioaptamer). Qualitative gel shift binding experiments with p50 also demonstrate that the nature of enhanced affinity and specificity can be attributed to the presence of sulfur. Collectively, these results demonstrate the feasibility of the thioaptamer in vitro combinatorial selection technology as a method for producing specific, high-affinity ligands to proteins.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Texas">
<name sortKey="King, David J" sort="King, David J" uniqKey="King D" first="David J." last="King">David J. King</name>
</region>
<name sortKey="Bassett, Suzanne E" sort="Bassett, Suzanne E" uniqKey="Bassett S" first="Suzanne E." last="Bassett">Suzanne E. Bassett</name>
<name sortKey="Fennewald, Susan A" sort="Fennewald, Susan A" uniqKey="Fennewald S" first="Susan A." last="Fennewald">Susan A. Fennewald</name>
<name sortKey="Gorenstein, David G" sort="Gorenstein, David G" uniqKey="Gorenstein D" first="David G." last="Gorenstein">David G. Gorenstein</name>
<name sortKey="Gorenstein, David G" sort="Gorenstein, David G" uniqKey="Gorenstein D" first="David G." last="Gorenstein">David G. Gorenstein</name>
<name sortKey="Herzog, Norbert K" sort="Herzog, Norbert K" uniqKey="Herzog N" first="Norbert K." last="Herzog">Norbert K. Herzog</name>
<name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name>
<name sortKey="Luxon, Bruce A" sort="Luxon, Bruce A" uniqKey="Luxon B" first="Bruce A." last="Luxon">Bruce A. Luxon</name>
<name sortKey="Shope, Robert" sort="Shope, Robert" uniqKey="Shope R" first="Robert" last="Shope">Robert Shope</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003365 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003365 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:EAEF7686C6B2B2B87278F7154BB46F5AEB9B5A1C
   |texte=   Combinatorial Selection and Binding of Phosphorothioate Aptamers Targeting Human NF-κB RelA(p65) and p50†
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021